These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11197805)

  • 1. Mixed connective tissue disease with multiple organ damage: successful treatment with plasmapheresis.
    Seguchi M; Soejima Y; Tateishi A; Iida H; Yamamoto M; Nakashima K; Murakami F; Ohashi S; Yamashita S; Maekawa T; Murashige A; Umemoto S; Matsuzaki M; Fukumoto Y
    Intern Med; 2000 Dec; 39(12):1119-22. PubMed ID: 11197805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
    Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
    Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment.
    Asherson RA
    Lupus; 1998; 7 Suppl 2():S55-62. PubMed ID: 9814675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.
    Szodoray P; Hajas A; Toth L; Szakall S; Nakken B; Soltesz P; Bodolay E
    Lupus; 2014 Sep; 23(10):1079-84. PubMed ID: 24795068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis.
    Flechtner KM; Baum K
    J Neurol Sci; 1994 Nov; 126(2):146-8. PubMed ID: 7853019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed connective tissue disease--goodbye to all that.
    Black C; Isenberg DA
    Br J Rheumatol; 1992 Oct; 31(10):695-700. PubMed ID: 1393377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Immunosuppressive Treatment of Mixed Connective Tissue Disease Complicated by Microscopic Polyangiitis.
    Sato S; Yashiro M; Matsuoka N; Uematsu M; Asano T; Kobayashi H; Watanabe H; Ohira H
    Tohoku J Exp Med; 2016 Jun; 239(2):111-6. PubMed ID: 27238624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed connective tissue disease associated with autoimmune hepatitis and thyroiditis.
    Tomsic M; Ferlan-Marolt V; Kveder T; Hojker S; Rozman B
    Ann Rheum Dis; 1992 Apr; 51(4):544-6. PubMed ID: 1586260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
    Parperis K
    J Clin Rheumatol; 2012 Aug; 18(5):261-2. PubMed ID: 22832296
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed connective tissue disease.
    Gunnarsson R; Hetlevik SO; Lilleby V; Molberg Ø
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):95-111. PubMed ID: 27421219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute scleroderma in stable mixed connective tissue disease: treatment by plasmapheresis.
    Crapper RM; Dowling JP; Mackay IR; Whitworth JA
    Aust N Z J Med; 1987 Jun; 17(3):327-9. PubMed ID: 3675385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-losing Gastroenteropathy Related to Mixed Connective Tissue Disease: A Case Report of a Successful Outcome and Literature Review.
    Kobayashi Y; Shimojima Y; Kondo Y; Takamatsu R; Miyazaki D; Kishida D; Sekijima Y; Ikeda SI
    Intern Med; 2017; 56(15):2057-2062. PubMed ID: 28768981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
    Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
    J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous calcification presenting in a patient with mixed connective tissue disease and cutaneous polyarteritis nodosa.
    Goolamali SI; Gordon P; Salisbury J; Creamer D
    Clin Exp Dermatol; 2009 Jul; 34(5):e141-4. PubMed ID: 19508582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular disease in mixed connective tissue disease (MCTD).
    Kondo H
    Intern Med; 2001 Dec; 40(12):1176. PubMed ID: 11813839
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscle involvement in mixed connective tissue disease.
    Hall S; Hanrahan P
    Rheum Dis Clin North Am; 2005 Aug; 31(3):509-17, vii. PubMed ID: 16084322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood mixed connective tissue disease.
    Yang YH; Tsai MJ; Lin SC; Lin MT; Chiang BL
    J Formos Med Assoc; 2000 Feb; 99(2):158-61. PubMed ID: 10770031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.